Chemical respiratory sensitization-Current status of mechanistic understanding, knowledge gaps and possible identification methods of sensitizers.
adverse outcome pathway (AOP)
chemical respiratory allergy
chemical sensitizer
chemical-induced hypersensitivity
key event
new approach methodology (NAM)
occupational asthma
respiratory sensitization
Journal
Frontiers in toxicology
ISSN: 2673-3080
Titre abrégé: Front Toxicol
Pays: Switzerland
ID NLM: 101777990
Informations de publication
Date de publication:
2024
2024
Historique:
received:
01
11
2023
accepted:
27
05
2024
medline:
13
8
2024
pubmed:
13
8
2024
entrez:
13
8
2024
Statut:
epublish
Résumé
Respiratory sensitization is a complex immunological process eventually leading to hypersensitivity following re-exposure to the chemical. A frequent consequence is occupational asthma, which may occur after long latency periods. Although chemical-induced respiratory hypersensitivity has been known for decades, there are currently no comprehensive and validated approaches available for the prospective identification of chemicals that induce respiratory sensitization, while the expectations of new approach methodologies (NAMs) are high. A great hope is that due to a better understanding of the molecular key events, new methods can be developed now. However, this is a big challenge due to the different chemical classes to which respiratory sensitizers belong, as well as because of the complexity of the response and the late manifestation of symptoms. In this review article, the current information on respiratory sensitization related processes is summarized by introducing it in the available adverse outcome pathway (AOP) concept. Potentially useful models for prediction are discussed. Knowledge gaps and gaps of regulatory concern are identified.
Identifiants
pubmed: 39135743
doi: 10.3389/ftox.2024.1331803
pii: 1331803
pmc: PMC11317441
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1331803Informations de copyright
Copyright © 2024 Hargitai, Parráková, Szatmári, Monfort-Lanzas, Galbiati, Audouze, Jornod, Staal, Burla, Chary, Gutleb, Lumniczky, Vandebriel and Gostner.
Déclaration de conflit d'intérêts
JG, RV, AG, and AC are National Experts contributing to the OECD Detailed Review Paper for respiratory sensitization. JG and RV were guest editors of Frontiers in Toxicology, at the time of submission. JG is co-inventor of EP3527653 and received funding from Egger GmbH, at the time the manuscript was composed. This had no impact on the content of the manuscript. AG and AC are co-inventors of WO 2018/122219 A1. AG is the founder of INVITROLIZE and SB is an employee of the same company. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.